Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still's Disease.
Xinyue HongXiaoming WangNingqi DaiYue SunHonglei LiuXiaobing ChengJunna YeHui ShiQiongyi HuJianfen MengZhuochao ZhouChengde YangJialin TengYutong SuHuihui ChiPublished in: Rheumatology and therapy (2024)
Patients with AOSD receiving medium or high-dose glucocorticoid therapy or JAK inhibitors had worse COVID-19 outcomes. Further work is needed to explore risk factors affecting COVID-19 outcomes and the impact of COVID-19 on disease activity in AOSD.
Keyphrases
- disease activity
- coronavirus disease
- sars cov
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- high dose
- juvenile idiopathic arthritis
- low dose
- type diabetes
- mesenchymal stem cells
- skeletal muscle
- bone marrow
- stem cell transplantation
- weight loss
- glycemic control